Invention Grant
- Patent Title: Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-N-benzylacetamide
-
Application No.: US16124281Application Date: 2018-09-07
-
Publication No.: US10669236B2Publication Date: 2020-06-02
- Inventor: Michael P. Smolinski
- Applicant: Athenex HK Innovative Limited
- Applicant Address: HK Sha Tin
- Assignee: Athenex HK Innovative Limited
- Current Assignee: Athenex HK Innovative Limited
- Current Assignee Address: HK Sha Tin
- Agency: Cooley LLP
- Agent Heidi A. Erlacher; Chen Chen
- Main IPC: C07D213/56
- IPC: C07D213/56 ; A61K31/4418
Abstract:
The present application provides solid Forms A, B, and C of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-N-benzylacetamide, and methods of preparing and using same. The compounds disclosed herein may be used in the treatment or prevention of a disease or condition in which a tyrosine kinase plays a role.
Public/Granted literature
- US20190071402A1 SOLID FORMS OF 2-(5-(4-(2-MORPHOLINOETHOXY)PHENYL)PYRIDIN-2-YL)-N-BENZYLACETAMIDE Public/Granted day:2019-03-07
Information query
